These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3042335)

  • 21. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort.
    Smáradóttir MI; Catrina SB; Brismar K; Norhammar A; Gyberg V; Mellbin LG
    Diab Vasc Dis Res; 2019 Jan; 16(1):22-27. PubMed ID: 30309264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin therapy in the elderly type 2 diabetic patient.
    Berger W
    Diabetes Res Clin Pract; 1988; 4 Suppl 1():24-8. PubMed ID: 3042329
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavior of glycemia and serum insulin level (IRI) in myocardial infarction after oral glucose load.
    Lawecki J; Kuch J; Ceremuzyński L; Rogala H
    Pol Med J; 1972; 11(2):281-90. PubMed ID: 5071515
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin, glycemic control, and C-reactive protein during myocardial infarction.
    Ceriello A
    Diabetes Care; 2004 Dec; 27(12):3017-8. PubMed ID: 15562230
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetes and acute myocardial infarction: the role of insulin therapy.
    Malmberg K; McGuire DK
    Am Heart J; 1999 Nov; 138(5 Pt 1):S381-6. PubMed ID: 10539801
    [No Abstract]   [Full Text] [Related]  

  • 26. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Rydén L; Wedel H; Vestberg D; Lind M
    Eur Heart J; 2013 Feb; 34(5):374-9. PubMed ID: 23144046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of dietary fiber (guar gum) on post-prandial blood glucose and blood insulin metabolism in the morning].
    Ceffa C; Sartori M; Carena L
    Minerva Dietol Gastroenterol; 1987; 33(1):83-7. PubMed ID: 3295596
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Type 1 diabetic patient: cave weight gain].
    Wirth A
    MMW Fortschr Med; 2013 Jun; 155(11):32. PubMed ID: 23901572
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.
    Schernthaner G; Kopp HP; Ristic S; Muzyka B; Peter L; Mitteregger G
    Horm Metab Res; 2004 Mar; 36(3):188-93. PubMed ID: 15057674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern insulin therapy].
    Waldhäusl W; Czerwenka-Howorka K
    Wien Med Wochenschr; 1985 Apr; 135(6-7):151-9. PubMed ID: 3923721
    [No Abstract]   [Full Text] [Related]  

  • 32. Satisfaction with glucose-lowering treatment and well-being in patients with type 2 diabetes and myocardial infarction: a DIGAMI2 QoL sub-study.
    Venskutonyte L; Brismar K; Rydén-Bergsten T; Rydén L; Kjellström B
    Diab Vasc Dis Res; 2013 May; 10(3):263-9. PubMed ID: 23188892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tamsulosin and hyperglycaemia in patients with diabetes.
    Borgsteede S; Bruggeman R; Hoefnagel R; Huiskes M; van Puijenbroek E
    Neth J Med; 2010 Mar; 68(3):141-3. PubMed ID: 20308713
    [No Abstract]   [Full Text] [Related]  

  • 34. [Insulin therapy in type 2 diabetes: a review of "when" over "how" up to "why"].
    Laimer M; Jenni S; Stettler C
    Praxis (Bern 1994); 2015 Feb; 104(4):181-5. PubMed ID: 25669222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of human and animal insulin on the responses to hypoglycemia in elderly patients with NIDDM.
    Meneilly GS; Milberg WP; Tuokko H
    Diabetes; 1995 Mar; 44(3):272-7. PubMed ID: 7883113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment on Home et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes care 2014;37:1499-1508.
    Conget I; Aronson R; Lee S; Cohen O; Reznik Y
    Diabetes Care; 2014 Nov; 37(11):e245-6. PubMed ID: 25342842
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeting glucose in acute myocardial infarction: has glucose, insulin, and potassium infusion missed the target?
    Chaudhuri A; Miller M; Nesto R; Rosenberg N; Dandona P
    Diabetes Care; 2007 Dec; 30(12):3026-8. PubMed ID: 17848612
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin glargine: cornerstone treatment for type 2 diabetes patients. Introduction.
    Garg SK
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():1-4. PubMed ID: 18577151
    [No Abstract]   [Full Text] [Related]  

  • 39. Silent hypoglycaemia at the diabetic clinic.
    Bradley KJ; Paton RC
    Diabet Med; 2001 May; 18(5):425-6. PubMed ID: 11472459
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of inhaled insulin on fasting and postprandial plasma glucose.
    Mikhail NE; Wali S; Cope D
    Ann Intern Med; 2007 Jun; 146(11):821; author reply 821-2. PubMed ID: 17548418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.